Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Cardiovascular Imaging Reports
Erschienen in: Current Cardiovascular Imaging Reports 2/2016

01.02.2016 | Intravascular Imaging (I.-K. Jang, Section Editor)

Experience with the Multimodality Near-Infrared Spectroscopy/Intravascular Ultrasound Coronary Imaging System: Principles, Clinical Experience, and Ongoing Studies

verfasst von: Barbara A. Danek, Aris Karatasakis, Ryan D. Madder, James E. Muller, Sean Madden, Subhash Banerjee, Emmanouil S. Brilakis

Erschienen in: Current Cardiovascular Imaging Reports | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Coronary near-infrared spectroscopy (NIRS) is a catheter-based imaging technique that can reliably detect lipid core plaques in the coronary artery wall. NIRS has now been combined with intravascular ultrasound (IVUS) in a single catheter. The combined NIRS/IVUS instrument provides all the information obtained by IVUS and adds lipid detection by NIRS. The instrument can detect large lipid core plaques that are at increased risk of causing periprocedural myocardial infarction during stenting. Preliminary data indicate that NIRS/IVUS imaging can identify vulnerable patients and vulnerable plaques associated with increased risk for spontaneous adverse cardiovascular events. Multiple ongoing studies are in progress to determine if NIRS/IVUS imaging can enhance the prediction of coronary events.
Literatur
1.
WHO. Cardiovascular diseases. 2015: Fact sheet No317.
2.
Goldstein JA, Demetriou D, Grines CL, Pica M, Shoukfeh M, O’Neill WW. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med. 2000;343:915–22.CrossRefPubMed
3.
Bourantas CV, Garcia-Garcia HM, Farooq V, et al. Clinical and angiographic characteristics of patients likely to have vulnerable plaques: analysis from the PROSPECT study. JACC Cardiovasc Imaging. 2013;6:1263–72.CrossRefPubMed
4.
Waxman S, Dixon SR, L’Allier P, et al. In vivo validation of a catheter-based near-infrared spectroscopy system for detection of lipid core coronary plaques: initial results of the SPECTACL study. J Am Coll Cardiol Img. 2009;2:858–68.CrossRef
5.
Gardner CM, Tan H, Hull EL, et al. Detection of lipid core coronary plaques in autopsy specimens with a novel catheter-based near-infrared spectroscopy system. J Am Coll Cardiol Img. 2008;1:638–48.CrossRef
6.
Garcia BA, Wood F, Cipher D, Banerjee S, Brilakis ES. Reproducibility of near-infrared spectroscopy for the detection of lipid core coronary plaques and observed changes after coronary stent implantation. Catheter Cardiovasc Interv. 2010;76:359–65.CrossRefPubMed
7.
Abdel-Karim AR, Rangan BV, Banerjee S, Brilakis ES. Intercatheter reproducibility of near-infrared spectroscopy for the in vivo detection of coronary lipid core plaques. Catheter Cardiovasc Interv. 2011;77:657–61.CrossRefPubMed
8.
Siesler HW, Ozaki Y, Kawata S, Heise HM. Near-infrared spectroscopy: principles, instruments, applications. Weinheim: Wiley-VCH; 2008.
9.
Kilic ID, Caiazzo G, Fabris E et al. Near-infrared spectroscopy-intravascular ultrasound: scientific basis and clinical applications. Eur Heart J Cardiovasc Imaging. 2015.
10.•
Stone GW, Maehara A, Muller JE, et al. Plaque characterization to inform the prediction and prevention of periprocedural myocardial infarction during percutaneous coronary intervention: the CANARY Trial (Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow). J Am Coll Cardiol Intv. 2015;8:927–36. CANARY is the first and only trial to date assessing the prophylactic use of embolic protection devices in lesions with large lipid core plaques. The study did not demonstrate any reduction in periprocedural myocardial infarction with use of embolic protection devices, but used a broad definition of myocardial infarction.CrossRef
11.
Madder RD, Smith JL, Dixon SR, Goldstein JA. Composition of target lesions by near-infrared spectroscopy in patients with acute coronary syndrome versus stable angina. Circ Cardiovasc Interv. 2012;5:55–61.CrossRefPubMed
12.
Puri R, Madder RD, Madden SP et al. Near-infrared spectroscopy enhances intravascular ultrasound assessment of vulnerable coronary plaque: a combined pathological and in vivo study. Arterioscler Thromb Vasc Biol. 2015.
13.
Kang SJ, Mintz GS, Pu J, et al. Combined IVUS and NIRS detection of fibroatheromas: histopathological validation in human coronary arteries. JACC Cardiovasc Imaging. 2015;8:184–94.CrossRefPubMed
14.
Brilakis ES, Banerjee S. How to detect and treat coronary fibroatheromas: the synergy between IVUS and NIRS. J Am Coll Cardiol Img. 2015;8:195–7.CrossRef
15.
Lee T, Yonetsu T, Koura K, et al. Impact of coronary plaque morphology assessed by optical coherence tomography on cardiac troponin elevation in patients with elective stent implantation. Circ Cardiovasc Interv. 2011;4:378–86.CrossRefPubMed
16.
Yonetsu T, Suh W, Abtahian F, et al. Comparison of near-infrared spectroscopy and optical coherence tomography for detection of lipid. Catheter Cardiovasc Interv. 2014;84:710–7.CrossRefPubMed
17.
Papayannis AC, Abdel-Karim AR, Mahmood A, et al. Association of coronary lipid core plaque with intrastent thrombus formation: a near-infrared spectroscopy and optical coherence tomography study. Catheter Cardiovasc Interv. 2013;81:488–93.CrossRefPubMed
18.
Kini AS, Motoyama S, Vengrenyuk Y, et al. Multimodality intravascular imaging to predict periprocedural myocardial infarction during percutaneous coronary intervention. JACC Cardiovasc Interv. 2015;8:937–45.CrossRefPubMed
19.
Choi BJ, Prasad A, Gulati R, et al. Coronary endothelial dysfunction in patients with early coronary artery disease is associated with the increase in intravascular lipid core plaque. Eur Heart J. 2013;34:2047–54.PubMedCentralCrossRefPubMed
20.
Varnava AM, Mills PG, Davies MJ. Relationship between coronary artery remodeling and plaque vulnerability. Circulation. 2002;105:939–43.CrossRefPubMed
21.
Inaba S, Mintz GS, Farhat NZ, et al. Impact of positive and negative lesion site remodeling on clinical outcomes: insights from PROSPECT. JACC Cardiovasc Imaging. 2014;7:70–8.CrossRefPubMed
22.
Schoenhagen P, Ziada KM, Kapadia SR, Crowe TD, Nissen SE, Tuzcu EM. Extent and direction of arterial remodeling in stable versus unstable coronary syndromes: an intravascular ultrasound study. Circulation. 2000;101:598–603.CrossRefPubMed
23.
Ota H, Magalhaes MA, Torguson R et al. The influence of lipid-containing plaque composition assessed by near-infrared spectroscopy on coronary lesion remodelling. Eur Heart J Cardiovasc Imaging. 2015.
24.
Townsend JC, Steinberg DH, Nielsen CD, et al. Comparison of lipid deposition at coronary bifurcations versus at nonbifurcation portions of coronary arteries as determined by near-infrared spectroscopy. Am J Cardiol. 2013;112:369–72.PubMedCentralCrossRefPubMed
25.
Zynda TK, Thompson CD, Hoang KC, et al. Disparity between angiographic coronary lesion complexity and lipid core plaques assessed by near-infrared spectroscopy. Catheter Cardiovasc Interv. 2013;81:529–37.CrossRefPubMed
26.
Ali ZA, Roleder T, Narula J, et al. Increased thin-cap neoatheroma and periprocedural myocardial infarction in drug-eluting stent restenosis: multimodality intravascular imaging of drug-eluting and bare-metal stents. Circ Cardiovasc Interv. 2013;6:507–17.CrossRefPubMed
27.
Dohi T, Maehara A, Moreno PR, et al. The relationship among extent of lipid-rich plaque, lesion characteristics, and plaque progression/regression in patients with coronary artery disease: a serial near-infrared spectroscopy and intravascular ultrasound study. Eur Heart J Cardiovasc Imaging. 2015;16:81–7.PubMedCentralCrossRefPubMed
28.••
Madder RD, Goldstein JA, Madden SP, et al. Detection by near-infrared spectroscopy of large lipid core plaques at culprit sites in patients with acute ST-segment elevation myocardial infarction. J Am Coll Cardiol Intv. 2013;6:838–46. This study demonstrated that coronary lesions causing STEMI have large lipid core plaques and proposed a maxLCBI 4mm >400 as a signature of plaques causing STEMI.
29.
Erlinge D. Near-infrared spectroscopy for intracoronary detection of lipid-rich plaques to understand atherosclerotic plaque biology in man and guide clinical therapy. J Intern Med. 2015;278:110–25.CrossRefPubMed
30.
Madder RD, Husaini M, Davis AT, et al. Detection by near-infrared spectroscopy of large lipid cores at culprit sites in patients with non-ST-segment elevation myocardial infarction and unstable angina. Catheter Cardiovasc Interv. 2015;86:1014–21.CrossRefPubMed
31.
Madder RD, Wohns DH, Muller JE. Detection by intracoronary near-infrared spectroscopy of lipid core plaque at culprit sites in survivors of cardiac arrest. J Invasive Cardiol. 2014;26:78–9.PubMed
32.
Wang L, Parodi G, Maehara A, et al. Variable underlying morphology of culprit plaques associated with ST-elevation myocardial infarction: an optical coherence tomography analysis from the SMART trial. Eur Heart J Cardiovasc Imaging. 2015;16:1381–9.CrossRefPubMed
33.
Witzenbichler B, Maehara A, Weisz G, et al. Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the assessment of dual antiplatelet therapy with drug-eluting stents (ADAPT-DES) study. Circulation. 2014;129:463–70.CrossRefPubMed
34.
Jang JS, Song YJ, Kang W, et al. Intravascular ultrasound-guided implantation of drug-eluting stents to improve outcome: a meta-analysis. JACC Cardiovasc Interv. 2014;7:233–43.CrossRefPubMed
35.
Ahn JM, Kang SJ, Yoon SH, et al. Meta-analysis of outcomes after intravascular ultrasound-guided versus angiography-guided drug-eluting stent implantation in 26,503 patients enrolled in three randomized trials and 14 observational studies. Am J Cardiol. 2014;113:1338–47.CrossRefPubMed
36.
Dixon SR, Grines CL, Munir A, et al. Analysis of target lesion length before coronary artery stenting using angiography and near-infrared spectroscopy versus angiography alone. Am J Cardiol. 2012;109:60–6.CrossRefPubMed
37.
Hanson ID, Goldstein JA, Dixon SR, Stone GW. Comparison of coronary artery lesion length by NIRS-IVUS versus angiography alone. Coron Artery Dis. 2015;26:484–9.CrossRefPubMed
38.
Dohi T, Weisz G, Powers ER, et al. TCT-583 the extent of lipid-rich plaque assessed by near-infrared spectroscopy may predict DES failure: a COLOR Registry analysis. J Am Coll Cardiol. 2013;62:B176–7.CrossRef
39.
Sakhuja R, Suh WM, Jaffer FA, Jang IK. Residual thrombogenic substrate after rupture of a lipid-rich plaque: possible mechanism of acute stent thrombosis? Circulation. 2010;122:2349–50.CrossRefPubMed
40.
Fernandez-Friera L, Garcia-Alvarez A, Romero A, et al. Lipid-rich obstructive coronary lesions is plaque characterization any important? J Am Coll Cardiol Img. 2010;3:893–5.CrossRef
41.
Goldstein JA, Grines C, Fischell T, et al. Coronary embolization following balloon dilation of lipid-core plaques. J Am Coll Cardiol Img. 2009;2:1420–4.CrossRef
42.
Saeed B, Banerjee S, Brilakis ES. Slow flow after stenting of a coronary lesion with a large lipid core plaque detected by near-infrared spectroscopy. EuroIntervention. 2010;6:545.CrossRefPubMed
43.
Schultz CJ, Serruys PW, van der Ent M, et al. First-in-man clinical use of combined near-infrared spectroscopy and intravascular ultrasound: a potential key to predict distal embolization and no-reflow? J Am Coll Cardiol. 2010;56:314.CrossRefPubMed
44.
Goldstein JA, Maini B, Dixon SR, et al. Detection of lipid-core plaques by intracoronary near-infrared spectroscopy identifies high risk of periprocedural myocardial infarction. Circ Cardiovasc Interv. 2011;4:429–37.CrossRefPubMed
45.
Raghunathan D, Abdel-Karim AR, Papayannis AC, et al. Relation between the presence and extent of coronary lipid core plaques detected by near-infrared spectroscopy with postpercutaneous coronary intervention myocardial infarction. Am J Cardiol. 2011;107:1613–8.CrossRefPubMed
46.
Brilakis ES, Abdel-Karim AR, Papayannis AC, et al. Embolic protection device utilization during stenting of native coronary artery lesions with large lipid core plaques as detected by near-infrared spectroscopy. Catheter Cardiovasc Interv. 2012;80:1157–62.CrossRefPubMed
47.
Maini A, Buyantseva L, Maini B. In vivo lipid core plaque modification with percutaneous coronary revascularization: a near-infrared spectroscopy study. J Invasive Cardiol. 2013;25:293–5.PubMed
48.•
Erlinge D, Harnek J, Goncalves I, Gotberg M, Muller JE, Madder RD. Coronary liposuction during percutaneous coronary intervention: evidence by near-infrared spectroscopy that aspiration reduces culprit lesion lipid content prior to stent placement. Eur Heart J Cardiovasc Imaging. 2015;16:316–24. This pilot study demonstrated that aspiration thrombectomy of lesions causing STEMI resulted in 28% reduction in culprit lesion lipid content.CrossRefPubMed
49.
Frobert O, Lagerqvist B, Olivecrona GK, et al. Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med. 2013;369:1587–97.CrossRefPubMed
50.
Jolly SS, Cairns JA, Yusuf S, et al. Randomized trial of primary PCI with or without routine manual thrombectomy. N Engl J Med. 2015;372:1389–98.CrossRefPubMed
51.•
Kini AS, Baber U, Kovacic JC, et al. Changes in Plaque Lipid Content After Short-Term Intensive Versus Standard Statin Therapy: The YELLOW Trial (Reduction in Yellow Plaque by Aggressive Lipid-Lowering Therapy). J Am Coll Cardiol. 2013;62:21–9. YELLOW was the first study that used NIRS to determine longitudinal changes on intracoronary plaque lipid content. High dose rosuvastatin for 7 weeks was associated with significant reduction in maxLCBI 4mm .
52.
Takano M, Mizuno K, Yokoyama S, et al. Changes in coronary plaque color and morphology by lipid-lowering therapy with atorvastatin: serial evaluation by coronary angioscopy. J Am Coll Cardiol. 2003;42:680–6.CrossRefPubMed
53.
Takarada S, Imanishi T, Kubo T, et al. Effect of statin therapy on coronary fibrous-cap thickness in patients with acute coronary syndrome: assessment by optical coherence tomography study. Atherosclerosis. 2009;202:491–7.CrossRefPubMed
54.
Robinson JG, Farnier M, Krempf M, et al. Efficacy and safety of alirocumab in reducing lipids and cardiovascular events. N Engl J Med. 2015;372:1489–99.CrossRefPubMed
55.
Sabatine MS, Giugliano RP, Wiviott SD, et al. Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. N Engl J Med. 2015;372:1500–9.CrossRefPubMed
56.
Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation. 1989;79:733–43.CrossRefPubMed
57.
Stone GW, Maehara A, Lansky AJ, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364:226–35.CrossRefPubMed
58.
Arbab-Zadeh A, Fuster V. The myth of the “vulnerable plaque”: transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment. J Am Coll Cardiol. 2015;65:846–55.CrossRefPubMed
59.
Libby P, Pasterkamp G. Requiem for the ‘vulnerable plaque’. Eur Heart J. 2015;36:2984–7.PubMed
60.••
Oemrawsingh RM, Cheng JM, Garcia-Garcia HM, et al. Near-infrared spectroscopy predicts cardiovascular outcome in patients with coronary artery disease. J Am Coll Cardiol. 2014;64:2510–8. First prospective cohort study to demonstrate that NIRS can assist in predicting the risk of future adverse cardiovascular events.CrossRefPubMed
61.
Madder RD, Husaini M, Davis AT et al. TCT-398 identification of vulnerable patients by intracoronary near-infrared spectroscopy. J Am Coll Cardiol. 2014: 64(11_S).
Metadaten
Titel
Experience with the Multimodality Near-Infrared Spectroscopy/Intravascular Ultrasound Coronary Imaging System: Principles, Clinical Experience, and Ongoing Studies
verfasst von
Barbara A. Danek
Aris Karatasakis
Ryan D. Madder
James E. Muller
Sean Madden
Subhash Banerjee
Emmanouil S. Brilakis
Publikationsdatum
01.02.2016
Verlag
Springer US
Erschienen in
Current Cardiovascular Imaging Reports / Ausgabe 2/2016
Print ISSN: 1941-9066
Elektronische ISSN: 1941-9074
DOI
https://doi.org/10.1007/s12410-015-9369-2

Neu im Fachgebiet Kardiologie

25.04.2024 | Hypotonie | Nachrichten

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 | Hypertonie | Nachrichten

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

24.04.2024 | Adipositas | Nachrichten

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 | ACC 2024 | Nachrichten

Komplette Revaskularisation bei Infarkt: Neue Studie setzt ein Fragezeichen
weitere anzeigen

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen